185 related articles for article (PubMed ID: 5322747)
1. [Study of oral hypoglycemic agents. VI. Comparative study on acute oral overload using tolbutamide and tolazamide in normal and diabetic subjects. Various aspects of the prolonged use of tolazamide in comparison with other sulfonylureas].
Pereira VG; Wajchenberg BL; Shnaider J
Arq Bras Endocrinol Metabol; 1965 Aug; 14(2):133-42. PubMed ID: 5322747
[No Abstract] [Full Text] [Related]
2. A comparison of the effects of tolazamide and tolbutamide upon blood glucose and serum insulin and lipid levels in diabetic subjects.
Moorhouse JA
Can Med Assoc J; 1967 Mar; 96(9):536-9. PubMed ID: 6019354
[TBL] [Abstract][Full Text] [Related]
3. [Acute hypoglycemizing activity of intravenous tolazamide and tolbutamide: comparative study in normal, diabetic and hepatopathic man. Preliminary note].
Milani R
Minerva Med; 1965 Sep; 56(74):3163-5. PubMed ID: 5833700
[No Abstract] [Full Text] [Related]
4. Hypoglycemic drugs.
Stehling L
Clin Anesth; 1974; 10(1):233-47. PubMed ID: 4598996
[No Abstract] [Full Text] [Related]
5. Comparative effects of acute intravenous loads of tolbutamide, acetohexamide and chlorpropamide in normal and diabetic subjects.
Wajchenberg BL; Pereira VG; Pupo AA
Arq Bras Endocrinol Metabol; 1965 Aug; 14(2):143-7. PubMed ID: 5322748
[No Abstract] [Full Text] [Related]
6. Blood glucose and drug levels in normal fasting subjects following single oral doses of tolazamide and chlorpropamide.
Novak E; Borden K; Vitti T; Hearron M
Mich Med; 1969 Dec; 68(24):1243-5. PubMed ID: 4901022
[No Abstract] [Full Text] [Related]
7. A study of the possible interaction of indoprofen with hypoglycemic sulfonylureas in diabetic patients.
Pedrazzi F; Bommartini F; Freddo J; Emanueli A
Eur J Rheumatol Inflamm; 1981; 4(1):26-31. PubMed ID: 7042358
[TBL] [Abstract][Full Text] [Related]
8. Value of tolazamide "'Tolanase') as an oral hypoglycaemic agent.
Tewari SN; Fletcher R
Br J Clin Pract; 1967 Sep; 21(9):455-6. PubMed ID: 4864489
[No Abstract] [Full Text] [Related]
9. The use of tolazamide in the treatment of diabetes mellitus.
Beidleman B; Prevatt AL; Palmer RC
J Fla Med Assoc; 1966 Mar; 53(3):191-3. PubMed ID: 5323398
[No Abstract] [Full Text] [Related]
10. [Oral treatment of diabetes mellitus with the new sulfonylurea tolazamide].
Vogel G; Krummel E
Arzneimittelforschung; 1969 Jul; 19(7):1128-30. PubMed ID: 5394514
[No Abstract] [Full Text] [Related]
11. [Effect of the sulfonylurea HB 419 (glibenclamide), tolbutamide and tolazamide on the lipolysis of isolated human fat cells].
Faulhaber JD; Ditschuneit H; Ditschuneit HH
Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1476-8. PubMed ID: 5394469
[No Abstract] [Full Text] [Related]
12. Potentiation of hypoglycemic effect of sulfonylureas by halofenate.
Jain AK; Ryan JR; McMahon FG
N Engl J Med; 1975 Dec; 293(25):1283-6. PubMed ID: 171574
[TBL] [Abstract][Full Text] [Related]
13. [On the value of the oral tolbutamide test for therapeutic indications].
Meyer H
Z Gesamte Inn Med; 1965 Jul; 20(14):443-5. PubMed ID: 5846884
[No Abstract] [Full Text] [Related]
14. Tolazamide in the treatment of diabetes mellitus: clinical experience and review of the literature.
Balodimos MC; Marble A
Curr Ther Res Clin Exp; 1971 Jan; 13(1):6-12. PubMed ID: 4992570
[No Abstract] [Full Text] [Related]
15. A clinical study of the metabolic effect of a new oral hypoglycemic agent: glipizide.
Iacono G; Ghionni A; Colucci M; Verde G; Caputo G
Int J Clin Pharmacol; 1974 Apr; 7(3):225-31. PubMed ID: 4850166
[No Abstract] [Full Text] [Related]
16. [Experimental studies on the mechanism of thrombocyte aggregation inhibition caused by sulfonylurea compounds. 2. Modification of blood sugar and thrombocyte aggregation by oral antidiabetics].
Losert W; Hoder A; Scholz C
Arzneimittelforschung; 1975 Feb; 25(2):170-9. PubMed ID: 804311
[No Abstract] [Full Text] [Related]
17. Glyburide and glipizide, second-generation oral sulfonylurea hypoglycemic agents.
Prendergast BD
Clin Pharm; 1984; 3(5):473-85. PubMed ID: 6435940
[TBL] [Abstract][Full Text] [Related]
18. [Results of oral therapy of diabetes mellitus with the new sulfonylurea tolazamide under ambulatory conditions].
Düntsch G
Arzneimittelforschung; 1970 Apr; 20(4):577-9. PubMed ID: 5467825
[No Abstract] [Full Text] [Related]
19. [Results of oral therapy of diabetes mellitus with the new sulfonylurea tolazamide under ambulatory conditions].
Düntsch G
Arzneimittelforschung; 1970 Apr; 20(4):575-9. PubMed ID: 5467824
[No Abstract] [Full Text] [Related]
20. CLINICAL STUDIES OF TOLAZAMIDE AND TOLBUTAMIDE: COMPARATIVE EFFECTIVENESS OF CONTROL OF DIABETES MELLITUS.
RENNIE CS; ANDERSON DO
Can Med Assoc J; 1963 Sep; 89(13):669-71. PubMed ID: 14077815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
